US 10525052
Abuse-deterrent drug formulations
granted A61KA61K31/13A61K31/135
Quick answer
US patent 10525052 (Abuse-deterrent drug formulations) held by Collegium Pharmaceutical, Inc. expires Mon Jan 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Collegium Pharmaceutical, Inc.
- Grant date
- Tue Jan 07 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61K, A61K31/13, A61K31/135, A61K31/20, A61K31/4458